CRP and cancer: Furthermore, serum ANRIL levels were elevated in individuals with type 2 diabetes and strongly correlated with pro-inflammatory markers leptin and hs-CRP (both p < 0.001), in line with findings from studies on diabetic and cancer patients42–45.